News
Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Media
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesFrom All AnglesMeeting of the MindsTraining Academy
Conferences
Conference CoverageConference Listing
Publications
More
CME/CE
Continuing Education
Resources
Case-Based Digest Rx Road MapEvents
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Partners
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Liver Cancer
    • Gastric Cancers
  • Genitourinary Cancer
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head and Neck Cancers
  • Hematology
    • Leukemia
    • Graft-Vs-Host Disease
    • Myeloproliferative Neoplasms
    • Multiple Myeloma
    • Lymphoma
  • Lung Cancer
  • Pediatric Cancer
  • Sarcomas
  • Skin Cancer
    • Melanoma
Advertisement

Holly Chitwood, DNP, APRN, FNP-C, AGACNP-BC, CPNP-AC

Advertisement

Articles by Holly Chitwood, DNP, APRN, FNP-C, AGACNP-BC, CPNP-AC

Photo of a nurse showing something on a clipboard to an older patient in bed and another woman, who is next to the patient and holding her hand.

Communication and Education: Improving Patient Outcomes With Bispecific T-Cell Engager Therapies

ByHolly Chitwood, DNP, APRN, FNP-C, AGACNP-BC, CPNP-AC
March 6th 2025
Advertisement

Latest Updated Articles

  • Photo of a nurse showing something on a clipboard to an older patient in bed and another woman, who is next to the patient and holding her hand.
    Communication and Education: Improving Patient Outcomes With Bispecific T-Cell Engager Therapies

    Published: March 6th 2025 | Updated:



Advertisement
Advertisement

Trending on Oncology Nursing News

1

Managing Acute and Late Adverse Effects of Breast Cancer Radiation

2

An NP’s Perspective: Supporting Derm Toxicities in Breast Cancer as a Team

3

NGS Streamlines Biomarker Testing in Solid Tumors

4

Osimertinib/Chemo Boosts OS in EGFR+ NSCLC With Poor Prognosis

5

Solo Sevabertinib Shows Durable Activity in HER2+ NSCLC

  • About Us
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • CureToday.com
  • OncLive.com
  • TargetedOnc.com
  • Advertise
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us